ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

DOCS Dr. Martens Plc

85.05
1.65 (1.98%)
12 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Dr. Martens Plc DOCS London Ordinary Share
  Price Change Price Change % Share Price Last Trade
1.65 1.98% 85.05 16:35:28
Open Price Low Price High Price Close Price Previous Close
87.60 82.75 87.60 85.05 83.40
more quote information »
Industry Sector
GENERAL RETAILERS

Dr. Martens DOCS Dividends History

Announcement Date Type Currency Dividend Amount Ex Date Record Date Payment Date
30/05/2024FinalGBP0.009929/08/202430/08/202401/10/2024
30/11/2023InterimGBP0.015604/01/202405/01/202402/02/2024
01/06/2023FinalGBP0.042808/06/202309/06/202318/07/2023
24/11/2022InterimGBP0.015605/01/202306/01/202303/02/2023
01/06/2022FinalGBP0.042809/06/202210/06/202219/07/2022
09/12/2021InterimGBP0.012213/01/202214/01/202204/02/2022

Top Dividend Posts

Top Posts
Posted at 30/5/2024 10:15 by hamhamham1
Look at birkenstock, market cap, their sales, profits and debt.
Docs look very cheap compared.
I think them or A&F will be the types of buyer here.
I don't think many designers are asset heavy, its about their brand and its perceived value.
Anyway, whether you buy or not, that's personal choice in investing i guess.

And in section 28 of the rns, see the leases amounts, half the net debt is made up of leases, personally I don't see them as typical debt, more a cost of doing business, they got a lot of retail outlets, etc.
Net debt is just calculated by subtracting total cash and cash equiv from short and long term debt (which Inc's leases).
Net debt isn't always a good indicator of the health of a company IMO. it doesn't show the whole story.

Yes sales are down and profits are vulnerable for the next year or so, but that attracts vultures, and if not, in a couple of years all will be cool IMO with EBITDA north of £300m IMO. and EBIT north of £250m.
Posted at 30/5/2024 07:46 by castleford tiger
i said it before but worth saying again...........this could run out of cash.

The £50 million spent buying shares back at an average 1.25 each has seen debt balloon.
18 months left on bank deals and some breaches will start.

First half will probably show a greater decline and a gross loss........

could be a fire-sale of stock as they chase cash.

Why pay a dividend rather than saving cash?

It could be saved but share holders may get wiped out.

Tiger
Posted at 18/4/2024 09:00 by woozle1
It was a strange warning and looked like an attempt to kitchen sink all the bad news for the new CEO (certainly any incoming CEO would not want to be landed with the outgoing CEO's errors). A comment in the Times was interesting, describing Kenny Wilson as starstruck by the US and hence the over-expansion.

The facts are EMEA and APAC,(the latter is the largest market for shoes globally) are doing well. Japan is a good market for DTC because such a large proportion of the population lives in the largest cities and winters are cold. I expect Docs to continue to do well there.

The US is not because wholesalers (read dept stores) are not ordering. It seems strange, therefore, that they loaded up with even more new stock. It may be that Docs was already committed to these orders and could not avoid this issue. Or that there is not a big market for boots on the West Coast (see below).  

In the 2024 H1 the company said "Our inventory is too high and will now right size
through FY25". Well, that statement looks wide of the mark.

Most branded products rely on some form of wholesale in the US as it is not feasible to cover the smaller metros economically. That's a simple fact of doing business in the US and even companies like GAW make a very large proportion of their sales through this channel.

The US is the largest economy as measured by GDP per capita. However, the decision to over-expand on the West Coast looks like a mistake and that the LA DC was poorly conceived. Warmer temps will dull the appetite for heavier boots and maybe they are selling more sandals there. I suspect this DC is draining the US performance and I would not be surprised if it shut down. Geography may be a dull word to brand consultants but it matters. I would hope that Permira makes this argument.

I own from £1 and will buy more. I think this is a relevant brand that has been around a long time (unlike Super Dry) and so long as the company continues to nurture it (and not indulge in massive discounting) I see no reason that it can not recover. And the balance sheet is in reasonable shape and should allow them to ride out this patch.
Posted at 18/4/2024 02:22 by papillon
free stock charts from uk.advfn.com


DOCS log chart. Great way for long term holders to lose money!
Posted at 17/4/2024 11:50 by itisonlymoney
darrin, thanks for the detail on the new ceo. Btw, does that look like the profile for a good fashion brand ceo? Big salary maybe. I have doubts. a senior director for apple retail - he's had lots of people around him to generate any success there. snr directors like to take all the credit if things go well, but out on their own, they often fail, so he's an unknown quantity at this point. does anyone here know how he did at wolf olins?

huckers, I've asked the same question. my instinct atm is that this fifth profit warning and the change of leadership (a necessary move) with an untested ceo who has apparently been on the board (as a non-exec rather than ops management) throughout this car crash, creates massive uncertainty on top of the forecast for much lower profits. there's nothing but shifting sand under the strategy and the forecasts, plus the global environment does not look good - major european war which it looks like russia will now win, and the prospect of a middle eastern war.

Docs has a high valuation based on its brand appeal but the retail market is not validating that appeal by buying the boots in huge numbers, so i think the share price has to reflect actual profit without a brand premium. that's my thinking and that leads me to guess that the share price is going steadily down for sometime now. i haven't got the confidence in that prediction to actually short the shares though, because there's no telling when a bid for the company could come. right now i'm watching. if the share price gets to 30p, i will almost certainly be a buyer.
Posted at 16/4/2024 22:02 by darrin1471
"new ceo seems to have been in charge of marketing"

Ije has only been the Chief Brand Officer since February.
An independent non executive at DOCS since the IPO.
A senior director of Apple retail for the last 6 years (40 stores)
11 years at brand consultancy agency Wolff Olins. CEO for 3 years. 150 employees.
Trained as an architect in Nigeria and the US.

The problems at DOCS appear to go beyond the "brand". Strategy (DTC), stock control and distribution to name a few.

Far to many risks and variables for me to invest
Posted at 16/4/2024 13:25 by essentialinvestor
As mentioned previously, gearing up the balance sheet (buy backs/aggressive store expansion) was unlikely to end well
given recent trading updates.

I could understand the rationale IF sales were powering ahead, but DOCS had already suffered multiple set backs.
Posted at 08/4/2024 14:31 by woozle1
So comparing the US and UK websites, (i) there is no discounting on core boots in either region and (ii) in the US there are more fashion sale items and more availability.

For example, Docs US Men's 144 items are listed at present as being on sale versus 55 in the UK. For women's, in the US 203 items are listed on sale whereas in the UK there are 78 items

This would imply that Docs are still working through the stock overhang.
Posted at 16/2/2024 10:40 by woozle1
We'll know if the worm has turned when the US wholesalers start restocking. According to the Co, 3rd party inventory levels are low but they now have a warehousing system that can now deliver. One focus for the Docs in 24/25 is on destocking (cash positions tend to improve with positive w/c businesses) and we should see an improvement in cash.

"Given the high proportion of continuity products we sell, with four out of five pairs being black and having a strong product margin structure, we have minimal markdown risk below cost. Inventory levels are higher than optimal and we plan to right-size inventory through the course of FY25."

One observation is they still have quite a few job vacancies in the US and wondering if this could be a potential headwind.

This quote from Marketing Weekly also sheds more light on the US problems:

"In the US, the brand has hired a new marketing vice-president with the goal of refocusing on the boots business in mind. While the shoes and sandals businesses are growing faster than boots, Dr Martens remains primarily a boot brand."

“As the number one brand in boots, our job is to keep boots relevant. Our European teams and our Japanese teams did that well; our American team didn’t,” he said. “We’ve got to learn from that."

Similar to GAW in the US which got carried away with Lord of the Rings (read fashionable sandals) and forgot to focus on the main Warhammer 40k and Warhammer Fantasy franchises (read boots). If DOCS can address this issue then there is no reason the shares should do very well.

DYOR
Posted at 26/1/2024 13:46 by woozle1
The issue of wholesale or 3rd party retailers is an interesting point, in particular in the US.

Reducing the wholesale channel is a good thing as it gives DOCS greater control over pricing and discounting and will almost certainly result in a drop in revenues and profitability in the short term. The US requires a dual strategy (DTC and 3rd party) because the economics of its stores only stack up in the major metro areas. Physical shoe retailing is also a tough gig as it requires a large range and a lot of dead space for stocking.

I suspect that DOCS is tightening up on the terms of trade and dropping accounts that don't sell much. Games Workshop went through a similar process some years ago. It requires nurturing the retailers that do the best job and this is not as easy as it sounds because it means having the right people (i.e. good account managers, good salespeople, and a sound marketing strategy).

Foreign companies often struggle to attract good local talent as locals prefer to work for US brands and US companies which means one often gets 2nd and 3rd rate applicants. It's the key reason that UK companies find it so hard in the US and why to get around this problem it's best to buy a US company where you can lock into the entrepreneurial drive of a hungry start-up with high-caliber individuals. The hope here is that Docs is a good enough brand to attract better talent than would usually be the case for a foreign company.

I'm pretty sure that this is a much better brand than Super Dry. It has much more cross-generational appeal (in London I see older blokes, middle-aged and young women, and kids wearing these shoes), it's been around much longer and management is investing heavily in it.

If you believe that DOCS isn't going away, this is a great entry point. Yes, the peaks will be inlfated fashion but the troughs are supported by a loyal customer base whose identity (see themselves as rebellious and independent thinkers)is tied up with the brand.

As ever, DYOR.
PSDOCS ceased to be work wear some time ago.

Your Recent History

Delayed Upgrade Clock